Immatics (IMTX) Other Accumulated Expenses (2019 - 2025)
Immatics' (IMTX) quarterly Other Accumulated Expenses came in at $6.5 million in Q4 2025, down 10.25% year-on-year from $7.3 million in Q4 2024, and up 21.45% quarter-over-quarter from $5.4 million in Q3 2025.
Immatics (IMTX) Other Accumulated Expenses (2019 - 2025) Analysis & Trends
Immatics has disclosed Other Accumulated Expenses across 7 years of filings, most recently posting $6.5 million for Q4 2025.
- Other Accumulated Expenses for Q4 2025 came in at $6.5 million, down 10.25% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.5 million (down 10.25% YoY), and the FY2025 annual result was $6.3 million, down 12.88% from the prior year.
- Other Accumulated Expenses came in at $6.5 million for Q4 2025 at Immatics, up from $5.4 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $16.6 million in Q3 2024 to a low of $1.7 million in Q1 2021.
- The 5-year median for Other Accumulated Expenses is $7.1 million (2024), against an average of $6.7 million.
- Across the five-year window, Other Accumulated Expenses sank 85.38% in 2021 and jumped 377.4% in 2023, its largest moves.
- Immatics' Other Accumulated Expenses stood at $2.9 million in 2021, then soared by 227.31% to $9.6 million in 2022, then climbed by 5.26% to $10.1 million in 2023, then declined by 27.7% to $7.3 million in 2024, then dropped by 10.25% to $6.5 million in 2025.
- The last three Other Accumulated Expenses figures came in at $6.5 million (Q4 2025), $5.4 million (Q3 2025), and $7.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.53 Mn |
| Sep 30, 2025 | 5.37 Mn |
| Jun 30, 2025 | 7.65 Mn |
| Mar 31, 2025 | 6.99 Mn |
| Dec 31, 2024 | 7.27 Mn |
| Sep 30, 2024 | 16.64 Mn |
| Jun 30, 2024 | 10.79 Mn |
| Mar 31, 2024 | 10.42 Mn |
| Dec 31, 2023 | 10.06 Mn |
| Sep 30, 2023 | 8.29 Mn |
| Jun 30, 2023 | 8.63 Mn |
| Mar 31, 2023 | 8.57 Mn |
| Dec 31, 2022 | 9.56 Mn |
| Sep 30, 2022 | 4.40 Mn |
| Jun 30, 2022 | 3.11 Mn |
| Mar 31, 2022 | 1.80 Mn |
| Dec 31, 2021 | 2.92 Mn |
| Sep 30, 2021 | 1.73 Mn |
| Jun 30, 2021 | 1.74 Mn |
| Mar 31, 2021 | 1.71 Mn |